Trials / Completed
CompletedNCT01318512
An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Patients With Chronic Kidney Disease Not On Dialysis
The Dosage of MIRCERA in the Treatment of Renal Anaemia in Patients With Chronic Renal Disease Who do Not Undergo Haemodialysis in Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 340 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This observational, prospective, multicenter study will describe the mean dose of Mircera (methoxy polyethylene glycol-epoetin beta) and the hemoglobin levels in patients with chronic kidney disease. Patients are not on dialysis and are naive to, or have received erythropoiesis stimulating agent treatment. Data will be collected for 10 months.
Conditions
Timeline
- Start date
- 2010-07-31
- Primary completion
- 2013-12-31
- Completion
- 2013-12-31
- First posted
- 2011-03-18
- Last updated
- 2017-07-05
- Results posted
- 2015-12-03
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT01318512. Inclusion in this directory is not an endorsement.